Rhinostics

Founded in 2018 and headquartered in St. Louis, Missouri, Rhinostics is a private, commercial-stage company operating in the diagnostics sector. It has developed a proprietary platform centered on its Rhinostics Swab and automated processing workstation, which together standardize and simplify nasal sample collection and preparation for downstream molecular testing. The company targets the high-volume infectious disease testing market, including respiratory panels and hospital-acquired infection screening, by offering solutions that reduce hands-on time and potential errors. Rhinostics is positioned as a tools and consumables provider, aiming to integrate its sample collection kits into the workflows of large diagnostic laboratories and health systems.

Integrated nasal sample collection and preparation system featuring a proprietary structural swab and an automated benchtop workstation for hands-off sample lysis and processing.

Rhinostics competes with large, diversified medical supply companies (e.g., Copan, Puritan, BD) that offer traditional swabs and transport systems, as well as with automation companies like Hamilton Company or Tecan that provide larger, more complex liquid handling robots. Its differentiation lies in its focused, integrated system designed specifically for the nasal sample-to-lysate workflow, aiming to be more cost-effective and space-efficient than general-purpose automation.